Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.

Isotretinoin may cause temporary, reversible facial hair growth in some women.

Scalp biopsy helps tell apart permanent and temporary hair loss types and guides treatment.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

Skin diseases are common and can significantly affect people's lives; better outcome measures and ethical clinical trials are needed to improve dermatology care.

Glucocorticoids are powerful anti-inflammatory drugs that must be used carefully to avoid serious side effects.

Skin changes are key for early diagnosis and treatment of rheumatic diseases.

People with alopecia areata often have higher rates of allergies and autoimmune diseases.

Frontal fibrosing alopecia is a poorly understood condition with increasing cases and unclear treatment effectiveness.

The article concludes that correctly diagnosing systemic causes of hair loss requires a detailed clinical evaluation and a systematic diagnostic approach.

Hair changes can indicate systemic diseases or medication effects.

Hepatitis C virus can cause skin diseases and dermatologists play a crucial role in identifying these conditions.

The COVID-19 pandemic led to fewer dermatology visits and changed the types of skin conditions patients experienced.

Biologics show promise in treating various stubborn skin diseases, but more research and better reimbursement criteria are needed.

New strategies like vitamin A and dextromethorphan can help reduce methotrexate side effects and improve patient adherence.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

A combined Dermatology and Rheumatology Clinic showed that skin issues often weren't linked to rheumatic diseases, highlighting the benefits of a team approach.

JAK inhibitors show promise for treating various skin diseases.

TNF-alpha inhibitors can cause various immune-related skin issues.

Vitamin D is crucial for skin health and managing skin diseases.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Auto-antibody testing is a useful but not definitive tool in diagnosing interstitial lung diseases, and using a specific algorithm could make testing more cost-effective.

Cyclophosphamide has serious side effects, but long-term follow-up can help manage risks.

Many patients in the rheumatology clinic adjusted or stopped their medications due to side effects.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

A patient with PPP had rare skin reactions to adalimumab, which improved after stopping smoking and continuing acitretin.

People with alopecia areata often have lower levels of zinc and vitamin D.

Isotretinoin therapy for acne can cause many reversible side effects, mainly mild skin conditions, and patient understanding of these effects can improve treatment adherence.

A man developed autoimmune issues after a transplant, improved with treatment, but died from leukemia relapse.